4.7 Article

A Novel Mitochondrial-Related Nuclear Gene Signature Predicts Overall Survival of Lung Adenocarcinoma Patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Genetics & Heredity

RRM2B Is Frequently Amplified Across Multiple Tumor Types: Implications for DNA Repair, Cellular Survival, and Cancer Therapy

Waleed Iqbal et al.

Summary: The study found that RRM2B is highly amplified in multiple tumor types, particularly in MYC-amplified tumors, and is associated with increased RRM2B mRNA expression. Investigation revealed that cancers with both RRM2B-amplified and MYC have a distinct pattern of amplification compared to other types of cancers.

FRONTIERS IN GENETICS (2021)

Review Oncology

Mitochondrial Control of Genomic Instability in Cancer

Massimo Bonora et al.

Summary: Cancer cells display genomic instability, with mitochondria playing a key role in responding to DNA alterations and affecting cell survival and the accumulation of mutations. Mitochondrial alterations in cancer can impact cell death pathways and metabolic plasticity, contributing to the evolution of the disease. Mitochondria are involved in regulating cell death and metabolic adaptation in tumor cells, and their role in supporting genomic instability in cancer is an important aspect that warrants further exploration.

CANCERS (2021)

Article Endocrinology & Metabolism

Melatonin inhibits lung cancer development by reversing the Warburg effect via stimulating the SIRT3/PDH axis

Xiangyun Chen et al.

Summary: The study found that melatonin can inhibit lung cancer growth by activating Sirt3 and PDH, leading to a reversal of the Warburg effect and an enhancement of mitochondrial energy metabolism.

JOURNAL OF PINEAL RESEARCH (2021)

Review Oncology

Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC

Michael J. Grant et al.

Summary: The treatment landscape of driver-negative non-small-cell lung cancer is rapidly changing due to the efficacy of immune-checkpoint inhibitors targeting PD-1 or PD-L1 as first-line therapy. Histological subtype and PD-L1 expression levels are crucial factors in regimen selection for patients, with emerging biomarkers and novel strategies potentially refining treatment paradigms in the future. Immune-checkpoint inhibitors are now standard-of-care therapies for patients with advanced-stage NSCLC, with various approved regimens available, highlighting the need for further research to optimize outcomes.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Review Biochemistry & Molecular Biology

PD-L1 regulation revisited: impact on immunotherapeutic strategies

Giulia Lucibello et al.

Summary: This review examines the pathways involved in PD-L1 expression and the druggable strategies being developed to enhance treatment response and prevent resistance in cancer patients. These new strategies will pave the way for effective treatment combinations in future oncology clinical trials.

TRENDS IN MOLECULAR MEDICINE (2021)

Article Clinical Neurology

ATP8A2-related disorders as recessive cerebellar ataxia

Claire Guissart et al.

JOURNAL OF NEUROLOGY (2020)

Article Oncology

YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling

Cheng Zhang et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)

Review Biochemistry & Molecular Biology

The Significance of Mitochondrial Dysfunction in Cancer

Yongde Luo et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Respiratory System

Mitochondrial dysfunction in lung ageing and disease

Suzanne M. Cloonan et al.

EUROPEAN RESPIRATORY REVIEW (2020)

Review Biochemistry & Molecular Biology

Abnormal Expression of Mitochondrial Ribosomal Proteins and Their Encoding Genes with Cell Apoptosis and Diseases

Guomin Huang et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Biochemistry & Molecular Biology

S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2

Lili Liu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Article Biochemistry & Molecular Biology

Cancer-associated fibroblasts modify lung cancer metabolism involving ROS and TGF-β signaling

Alberto Cruz-Bermudez et al.

FREE RADICAL BIOLOGY AND MEDICINE (2019)

Article Biotechnology & Applied Microbiology

Pattern of mitochondrial D-loop variations and their relation with mitochondrial encoded genes in pediatric acute myeloid leukemia

Anudishi Tyagi et al.

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2018)

Article Multidisciplinary Sciences

Mitochondrial mutations drive prostate cancer aggression

Julia F. Hopkins et al.

NATURE COMMUNICATIONS (2017)

Article Genetics & Heredity

Integrated genomic analysis of mitochondrial RNA processing in human cancers

Youssef Idaghdour et al.

GENOME MEDICINE (2017)

Article Multidisciplinary Sciences

Transcriptomic analysis of mitochondrial TFAM depletion changing cell morphology and proliferation

Woo Rin Lee et al.

SCIENTIFIC REPORTS (2017)

Review Biochemistry & Molecular Biology

Mitochondria and Cancer

Sejal Vyas et al.

Article Medicine, Research & Experimental

Role of mitochondrial dysfunction in cancer progression

Chia-Chi Hsu et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2016)

Review Biochemistry & Molecular Biology

Mitochondria and Cancer

Wei-Xing Zong et al.

MOLECULAR CELL (2016)

Article Oncology

Genomic landscape of DNA repair genes in cancer

Young Kwang Chae et al.

ONCOTARGET (2016)

Article Biochemistry & Molecular Biology

OXPHOS dysfunction regulates integrin-β1 modifications and enhances cell motility and migration

Joana B. Nunes et al.

HUMAN MOLECULAR GENETICS (2015)

Article Multidisciplinary Sciences

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Paul C. Tumeh et al.

NATURE (2014)

Review Biochemistry & Molecular Biology

Tumor glycolysis as a target for cancer therapy: progress and prospects

Shanmugasundaram Ganapathy-Kanniappan et al.

MOLECULAR CANCER (2013)

Article Biochemistry & Molecular Biology

Cytochrome c oxidase is activated by the oncoprotein Ras and is required for A549 lung adenocarcinoma growth

Sucheta Telang et al.

MOLECULAR CANCER (2012)

Review Biochemistry & Molecular Biology

SDH mutations in cancer

Chiara Bardella et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2011)

Review Neurosciences

Mitochondria: The Next (Neurode)Generation

Eric A. Schon et al.

NEURON (2011)

Article Clinical Neurology

Analysis of the IDH1 codon 132 mutation in brain tumors

Joerg Balss et al.

ACTA NEUROPATHOLOGICA (2008)

Letter Medicine, General & Internal

Somatic SDHB mutation in an extraadrenal pheochromocytoma

Francien H. van Nederveen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Review Medicine, General & Internal

Mechanisms of disease: Mitochondrial respiratory-chain diseases

S DiMauro et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Article Genetics & Heredity

Mutations in SDHC cause autosomal dominant paraganglioma, type 3

S Niemann et al.

NATURE GENETICS (2000)